Posts Tagged ‘Medstro’

Now on the NEJM Group Open Forum

Posted by • April 27th, 2015

There’s a lot happening on the NEJM Group Open Forum: Talk with authors and experts about a new study involving multiple US neonatal intensive care units that demonstrated a substantial increase in admissions for neonatal abstinence syndrome between 2004 and 2011, as well as increases in associated length of stay and in the percentage of NICU days nationwide… Read More…

NEJM Group Open Forum – Take part in the conversation!

Posted by • April 7th, 2015

These active and engaging discussions are happening now on the NEJM Group Open Forum on Medstro.com. Read the questions and answers posted so far, like, share and comment to become a part of the conversation. Women Transforming the Culture of Medicine: How do women physicians communicate with each other and with their male colleagues? Can the… Read More…

New Topics on the NEJM Group Open Forum

Posted by • March 19th, 2015

There’s a lot to talk about on the NEJM Group Open Forum. Read the discussion, like, share and comment to become a part of these active and engaging conversations. Reviving Research to Prevent Gun Violence: If you were given a research grant to investigate some aspect of firearm violence, how would you direct those resources? How… Read More…

New Conversations on the NEJM Group Open Forum

Posted by • February 26th, 2015

Now on the NEJM Group Open Forum, NEJM authors and experts are discussing: What had historically been their approach to the introduction of peanut in their infant patients with severe eczema, egg allergy, or both, even before the publication of the LEAP trial of peanut allergy. Their thoughts on the opportunities for precision medicine in preventative… Read More…

Two New NEJM Quick Takes – Watch them Now!

Posted by • December 22nd, 2014

The latest Quick Take animation, narrated by Editor-in-Chief Jeffrey Drazen, summarizes a new study that explores the efficacy of a not-so-new but largely unknown over-the-counter medication for smoking cessation. In the randomized trial of smokers who called New Zealand’s national Quitline, cytisine (a partial nicotinic acetylcholine receptor agonist) was superior to nicotine-replacement therapy in helping… Read More…

New Conversations on the NEJM Group Open Forum

Posted by • December 18th, 2014

Will the results of the MR CLEAN trial change the standard of care for patients with acute ischemic stroke? Ask the authors and other experts in the field in the latest discussion about NEJM original research. From the NEJM CareerCenter “Fascinating Physician” series, meet Dr. Wen Dombrowski, a geriatrics physician executive who develops technology, business, and… Read More…

Join the conversation on the NEJM Group Open Forum

Posted by • December 9th, 2014

Two active conversations await your participation on the NEJM Group Open Forum, powered by Medstro, a social professional network for physicians. Dr. Julian Seifter, author of the recent Review Article, “Integration of Acid-Base and Electrolyte Disorders,” is on hand to answer your questions on this topic. Meet “Fascinating Physician” Andrey Ostrovsky, a Pediatrics Senior Resident at Boston Children’s Hospital whose numerous… Read More…

NEJM Group Open Forum

Posted by • November 13th, 2014

NEJM Group has joined with Medstro, a social professional network for physicians, to create the NEJM Group Open Forum, a series of live discussions intended to generate active conversation around important–and sometimes controversial–ideas. We’ve brought together authors, experts in the field, and many of your peers to discuss these three topics, now active and ready… Read More…